Methyl-hydroxylation and subsequent oxidation to produce carboxylic acid is the major metabolic pathway of tolbutamide in chimeric TK-NOG mice transplanted with human hepatocytes

References

• Ahmed Laskar, A. and Younus, H., 2019. Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis. Drug metabolism reviews, 51 (1), 42–64.
   PubMed Web of Science ®Google Scholar
• Algar, E.M., Seeley, T.L., and Holmes, R.S., 1983. Purification and molecular properties of mouse alcohol dehydrogenase isozymes. European journal of biochemistry, 137 (1-2), 139–147.
   PubMedGoogle Scholar
• Baillie, T.A., 2008. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. Chemical research in toxicology, 21 (1), 129–137.
   PubMed Web of Science ®Google Scholar
• Bissig, K.D., et al., 2018. P450-Humanized and human liver chimeric mouse models for studying xenobiotic metabolism and toxicity. Drug metabolism and disposition: the biological fate of chemicals, 46 (11), 1734–1744.
   PubMed Web of Science ®Google Scholar
• Brown, C.M., Reisfeld, B., and Mayeno, A.N., 2008. Cytochromes P450: a structure-based summary of biotransformations using representative substrates. Drug metabolism reviews, 40 (1), 1–100.
   PubMed Web of Science ®Google Scholar
• Crouch, R.D., et al., 2017. Species-specific involvement of aldehyde oxidase and xanthine oxidase in the metabolism of the pyrimidine-containing mGlu5-negative allosteric modulator VU0424238 (Auglurant). Drug metabolism and disposition: the biological fate of chemicals, 45 (12), 1245–1259.
   PubMed Web of Science ®Google Scholar
• Duester, G., et al., 1999. Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. Biochemical pharmacology, 58 (3), 389–395.
   PubMed Web of Science ®Google Scholar
• Fujiwara, R., Yoda, E., and Tukey, R.H., 2018. Species differences in drug glucuronidation: humanized UDP-glucuronosyltransferase 1 mice and their application for predicting drug glucuronidation and drug-induced toxicity in humans. Drug metabolism and pharmacokinetics, 33 (1), 9–16.
   PubMed Web of Science ®Google Scholar
• Garattini, E., Fratelli, M., and Terao, M., 2009. The mammalian aldehyde oxidase gene family. Human genomics, 4 (2), 119–130.
   PubMedGoogle Scholar
• Gee, S.J., Green, C.E., and Tyson, C.A., 1984. Comparative metabolism of tolbutamide by isolated hepatocytes from rat, rabbit, dog, and squirrel monkey. Drug metabolism and disposition: the biological fate of chemicals, 12 (2), 174–178.
   PubMed Web of Science ®Google Scholar
• Haseba, T. and Ohno, Y., 2010. A new view of alcohol metabolism and alcoholism-role of the high-Km Class III alcohol dehydrogenase (ADH3). International journal of environmental research and public health, 7 (3), 1076–1092.
   PubMed Web of Science ®Google Scholar
• Hasegawa, M., et al., 2011. The reconstituted ‘humanized liver’ in TK-NOG mice is mature and functional. Biochemical and biophysical research communications, 405 (3), 405–410.
   PubMed Web of Science ®Google Scholar
• Henderson, C.J., et al., 2019. An extensively humanized mouse model to predict pathways of drug disposition and drug/drug interactions, and to facilitate design of clinical trials. Drug metabolism and disposition: the biological fate of chemicals, 47 (6), 601–615.
   PubMed Web of Science ®Google Scholar
• Kamimura, H., et al., 2015. Formation of the accumulative human metabolite and human-specific glutathione conjugate of diclofenac in TK-NOG chimeric mice with humanized livers. Drug metabolism and disposition: the biological fate of chemicals, 43 (3), 309–316.
   PubMed Web of Science ®Google Scholar
• Kitamura, S., Sugihara, K., and Ohta, S., 2006. Drug-metabolizing ability of molybdenum hydroxylases. Drug metabolism and pharmacokinetics, 21 (2), 83–98.
   PubMed Web of Science ®Google Scholar
• Knodell, R.G., et al., 1987. Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition. The journal of pharmacology and experimental therapeutics, 241 (3), 1112–1119.
   PubMed Web of Science ®Google Scholar
• Koppaka, V., et al., 2012. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacological reviews, 64 (3), 520–539.
   PubMed Web of Science ®Google Scholar
• Li, T.K., et al., 1977. Isolation of pi-alcohol dehydrogenase of human liver: is it a determinant of alcoholism? Proceedings of the National Academy of Sciences of the United States of America, 74 (10), 4378–4381.
   PubMed Web of Science ®Google Scholar
• Martignoni, M., Groothuis, G.M., and de Kanter, R., 2006. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert opinion on drug metabolism & toxicology, 2 (6), 875–894.
   PubMed Web of Science ®Google Scholar
• Massey, V., et al., 1970. On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazolo[3,4-d]pyrimidines. The journal of biological chemistry, 245 (11), 2837–2844.
   PubMed Web of Science ®Google Scholar
• McDaniel, H.G., Podgainy, H., and Bressler, R., 1969. The metabolism of tolbutamide in rat liver. Journal of pharmacology and experimental therapeutics., 167, 91–97.
   PubMed Web of Science ®Google Scholar
• Miners, J.O. and Birkett, D.J., 1996. Use of tolbutamide as a substrate probe for human hepatic cytochrome P450 2C9. Methods in enzymology, 272, 139–145.
   PubMed Web of Science ®Google Scholar
• Mohnike, G., Wittenhagen, G., and Langenbeck, W., 1958. Uber des Ausscheidengsprodukt von N-(4-Mathyl-benzolsulfonyl)- Nt-butyl harnstoff beim Hunt. Die naturwissenschaften, 45 (1), 13–13.
   Google Scholar
• Nirogi, R., et al., 2014. Identification of a suitable and selective inhibitor towards aldehyde oxidase catalyzed reactions. Xenobiotica; the fate of foreign compounds in biological systems, 44 (3), 197–204.
   PubMed Web of Science ®Google Scholar
• Ogawa, S.I., et al., 2020. Prediction of circulating human metabolites of pemafibrate, a novel antidyslipidemic drug, using chimeric mice with humanized liver. Xenobiotica; the fate of foreign compounds in biological systems, 50 (7), 769–775.
   PubMed Web of Science ®Google Scholar
• Pietruszko, R., 1975. Human liver alcohol dehydrogenase-inhibition of methanol activity by pyrazole, 4-methylpyrazole, 4-hydroxymethylpyrazole and 4-carboxypyrazole. Biochemical pharmacology, 24 (17), 1603–1607.
   PubMed Web of Science ®Google Scholar
• Rashidi, M.R., et al., 1997. In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver. Drug metabolism and disposition: the biological fate of chemicals, 25 (7), 805–813.
   PubMed Web of Science ®Google Scholar
• Scheer, N., et al., 2014. Deletion of 30 murine cytochrome p450 genes results in viable mice with compromised drug metabolism. Drug metabolism and disposition: the biological fate of chemicals, 42 (6), 1022–1030.
   PubMed Web of Science ®Google Scholar
• Suemizu, H., et al., 2018. Chimeric mice with humanized liver as a model for testing organophosphate and carbamate pesticide exposure. Pest management science, 74 (6), 1424–1430.
   PubMed Web of Science ®Google Scholar
• Terao, M., et al., 2020. Evolution, expression, and substrate specificities of aldehyde oxidase enzymes in eukaryotes. The journal of biological chemistry, 295 (16), 5377–5389.
   PubMed Web of Science ®Google Scholar
• Terao, M., et al., 2016. Structure and function of mammalian aldehyde oxidases. Archives of toxicology, 90 (4), 753–780.
   PubMed Web of Science ®Google Scholar
• Thomas, R.C. and Ikeda, G.J., 1966. The metabolic fate of tolbutamide in man and in the rat. Journal of medicinal chemistry, 9 (4), 507–510.
   PubMed Web of Science ®Google Scholar
• Tsutsumi, M., et al., 1988. Hepatic aldehyde dehydrogenase isoenzymes: differences with respect to species. Alcohol (Fayetteville, N.Y.).), 5 (1), 33–38.
   PubMed Web of Science ®Google Scholar
• Uehara, S., et al., 2019. Expression and inducibility of cytochrome P450s in human hepatocytes isolated from chimeric mice with humanised livers. Xenobiotica, 49 (6), 678–687.
   PubMed Web of Science ®Google Scholar
• Uehara, S., et al., 2020a. Human aldehyde oxidase 1-mediated carbazeran oxidation in chimeric TK-NOG mice transplanted with human hepatocytes. Drug metabolism and disposition: the biological fate of chemicals, 48 (7), 580–586.
   PubMed Web of Science ®Google Scholar
• Uehara, S., et al., 2020b. Metabolism of desloratadine by chimeric TK-NOG mice transplanted with human hepatocytes. Xenobiotica; the fate of foreign compounds in biological systems, 50 (6), 733–740.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. 2016. Guidance for industry: safety testing of drug metabolites.
   Google Scholar